BioPharma – Page 271

Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent

Post author:Sam
Post published:February 7, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

This Could be Biogen's Next $1 Billion Blockbuster

Post author:Sam
Post published:February 7, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x470-biogen.jpg" NAME"This Could be Biogen's Next $1 Billion Blockbuster" ALT"This Could be Biogen's Next $1 Billion Blockbuster"February 8, 2017By Alex Keown, BioSpace.com Breaking News StaffBOSTON <A HREF"http... Source: BioSpace

Veracyte To Expand Patient Access To The Afirma Gene Expression Classifier In Thyroid Cancer Diagnosis Through Agreement With Quest Diagnostics

Post author:Sam
Post published:February 7, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Sinking Teva Needs a New CEO But May Need to Up Salary

Post author:Sam
Post published:February 7, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-teva.jpg" NAME"Sinking Teva Needs a New CEO But May Need to Up Salary" ALT"Sinking Teva Needs a New CEO But May Need to Up Salary"February 8, 2017By Alex Keown,…

Catalent Reports Second Quarter Fiscal Year 2017 Results

Post author:Sam
Post published:February 6, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire

Post author:Sam
Post published:February 6, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-genentech.jpg" NAME"Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire" ALT"Genentech's $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire"February 7, 2017By Mark Terry, BioSpace... Source: BioSpace

Engineers Harness Stomach Acid To Power Tiny Sensors, MIT Study Reveals

Post author:Sam
Post published:February 6, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

4 Biotech Stocks Worthy Enough to be Brokers' Favorites

Post author:Sam
Post published:February 6, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"4 Biotech Stocks Worthy Enough to be Brokers' Favorites" ALT"4 Biotech Stocks Worthy Enough to be Brokers' Favorites"February 7, 2017By Mark Terry, BioSpace.com Breaking News StaffWhen in Rome...…

Berg Announces Appointment Of As Chief Operating Officer

Post author:Sam
Post published:February 6, 2017
Post category:BioPharma

Life Sciences Jobs ... Source: BioSpace

GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected

Post author:Sam
Post published:February 6, 2017
Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-job-cuts.jpg" NAME"GE Healthcare to Shutter Maryland Plant, Nearly 200 Employees Affected" ALT"Merck KGaA Spinout Prexton Nabs $31 Million to Fund Phase II Parkinson's TrialsGE Healthcare to Shutter Maryland Plant,…